Enzalutamide monotherapy:Results from a phase 2 study in hormone naïve prostate cancer patients.

B. Tombal; M.  Borre; Per Rathenborg; P.  Webrouck; A. Heidenreich; Peter Iversen; E.  Baskin-Bey; F.  Perabo; D.  Phung; M.R.  Smith

Enzalutamide monotherapy:Results from a phase 2 study in hormone naïve prostate cancer patients.

B. Tombal, M. Borre, Per Rathenborg, P. Webrouck, A. Heidenreich, Peter Iversen, E. Baskin-Bey, F. Perabo, D. Phung, M.R. Smith

Urinvejssygdomme

Originalsprog	Engelsk
Publikationsdato	2013
Status	Udgivet - 2013
Begivenhed	28th Annual Congress, European Association of Urology - Milan, Italien Varighed: 15 mar. 2013 → 19 mar. 2013 Konferencens nummer: 28

Konference

Konference	28th Annual Congress, European Association of Urology
Nummer	28
Land/Område	Italien
By	Milan
Periode	15/03/2013 → 19/03/2013

Citationsformater

@conference{36c2184069b14e8bb8f091819eb910fb,

title = "Enzalutamide monotherapy:Results from a phase 2 study in hormone na{\"i}ve prostate cancer patients.",

author = "B. Tombal and M. Borre and Per Rathenborg and P. Webrouck and A. Heidenreich and Peter Iversen and E. Baskin-Bey and F. Perabo and D. Phung and M.R. Smith",

year = "2013",

language = "English",

note = "null ; Conference date: 15-03-2013 Through 19-03-2013",

}

TY - ABST

T1 - Enzalutamide monotherapy:Results from a phase 2 study in hormone naïve prostate cancer patients.

AU - Tombal, B.

AU - Borre, M.

AU - Rathenborg, Per

AU - Webrouck, P.

AU - Heidenreich, A.

AU - Iversen, Peter

AU - Baskin-Bey, E.

AU - Perabo, F.

AU - Phung, D.

AU - Smith, M.R.

N1 - Conference code: 28

PY - 2013

Y1 - 2013

M3 - Conference abstract for conference

Y2 - 15 March 2013 through 19 March 2013

ER -